目錄:MedChemExpress LLC>>生化試劑>> SGI-1027 | MCE
CAS | 1020149-73-8 | 純度 | 99.35% |
---|---|---|---|
分子量 | 461.52 | 分子式 | C??H??N?O |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mg |
貨號 | HY-13962 | 應用領域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學研究或藥證申報,,我們不為任何個人用途提供產(chǎn)品和服務,。
CAS No. : 1020149-73-8
產(chǎn)品活性:SGI-1027 is a DNA methyltransferase (DNMT) inhibitor, with IC50s of 7.5 μM, 8 μM, and 12.5 μM for DNMT3B, DNMT3A, and DNMT1 with poly(dI-dC) as substrate.
研究領域:Epigenetics | Apoptosis
作用靶點:DNA Methyltransferase | Apoptosis
In Vitro: SGI-1027 is a DNMT inhibitor, with IC50s of 7.5 μM, 8 μM, and 12.5 μM for DNMT3B, DNMT3A, and DNMT1 with poly(dI-dC) as substrate. SGI-1027 shows an IC50 of 6 μM for DNMT1 (hemimethylated DNA). SGI-1027 (1, 2.5, or 5 µM) causes selective degradation of DNMT1 in several human cancer cell lines, but shows little or no cytotoxic effect on rat hepatoma cells, and does not induce apoptosis in rat hepatoma cells. SGI-1027 shows an EC50 of 0.9 μM for hDNMT3A, and causes cytotoxicity on KG-1 cells, with an EC50 of 4.4 μM.
相關產(chǎn)品:Bioactive Compound Library Plus | Apoptosis Compound Library | Epigenetics Compound Library | Anti-Cancer Compound Library | Reprogramming Compound Library | Anti-Blood Cancer Compound Library | Transcription Factor-Targeted Library | SY-5609 | BRD4 Inhibitor-18 | 8α-Tigloyloxyhirsutinolide 13-O-acetate | AAPK-25 | Dutasteride-13C6 | Oleic acid-13C | Abacavir sulfate | Meloxicam-d3-1 | Thailanstatin D | SB-218078 | Toyocamycin | Sorafenib-d4 | Busulfan | PTC-028 | Dinaciclib | CR-1-31-B | 142I5 | Farudodstat | Ecteinascidin 770 | AT9283 | Staurosporine | SNS-032 | AZA1 | Bleomycin A5 | Xevinapant | Mangiferin | Cambinol | hGGPPS-IN-1 | Bafetinib | Dinoprost-d4
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,我們致力于為*科研客戶提供前沿的高品質小分子活性化合物,;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領,;
• 產(chǎn)品種類涵蓋各種重組蛋白,,多肽,常用試劑盒 ,,更有 PROTAC,、ADC 等特色產(chǎn)品,廣泛應用于新藥研發(fā),、生命科學等科研項目,;
• 提供虛擬篩選,離子通道篩選,,代謝組學分析檢測分析,,藥物篩選等專業(yè)技術服務;
• 設有專業(yè)的實驗中心和嚴格的質控,、驗證體系,;
• 提供 LC/MS、NMR,、HPLC,、手性分析、元素分析等各項質檢報告,,確保產(chǎn)品的高純度,、高品質;
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證,;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果,;
• 專業(yè)團隊跟蹤最新的制藥及生命科學研究進展,為您提供*新的活性化合物,;
• 與世界各大制藥公司及著名科研機構建立了長期的合作,。